XML 66 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Investments Equity Method investments (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Feb. 28, 2022
Nov. 30, 2021
Feb. 28, 2021
Nov. 30, 2020
Feb. 28, 2022
Feb. 28, 2021
Aug. 31, 2021
Schedule of Equity Method Investments [Line Items]              
Other Investments $ 134,224       $ 134,224   $ 128,816
Net income (loss) attributable to CHS Inc. 219,000   $ (38,229)   670,961 $ 31,442  
Gross Profit 268,998   101,720   788,906 279,824  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 218,896 $ 451,943 $ (38,358) $ 69,369 670,839 31,011  
Other Equity Method Investments [Member]              
Schedule of Equity Method Investments [Line Items]              
Equity Method Investments 245,537       245,537   232,923
CF Nitrogen LLC [Member]              
Schedule of Equity Method Investments [Line Items]              
Equity Method Investments 2,712,295       2,712,295   2,667,164
Net income (loss) attributable to CHS Inc.         292,592 53,033  
Revenues         3,018,167 1,285,625  
Gross Profit         1,547,086 321,565  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest         1,522,292 297,297  
Ventura Foods, LLC              
Schedule of Equity Method Investments [Line Items]              
Equity Method Investments 411,176       411,176   388,612
Ardent Mills LLC [Member]              
Schedule of Equity Method Investments [Line Items]              
Equity Method Investments 233,898       233,898   220,132
TEMCO, LLC              
Schedule of Equity Method Investments [Line Items]              
Equity Method Investments $ 51,580       51,580   $ 31,464
Ventura Foods, Ardent Mills and TEMCO              
Schedule of Equity Method Investments [Line Items]              
Net income (loss) attributable to CHS Inc.         67,908 51,729  
Revenues         4,677,071 5,502,631  
Gross Profit         539,044 422,154  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest         $ 268,319 $ 188,403